Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baoshipu (Shanghai) Biotechnology is a specialized medical technology company dedicated to the advancement of clinical mass spectrometry in China. The company provides integrated solutions that combine high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) reagent kits with proprietary automated sample pretreatment systems. Their product portfolio focuses on high-growth diagnostic areas such as therapeutic drug monitoring (TDM) for transplant patients, vitamin testing, and endocrine hormone analysis. By addressing the technical complexities of mass spectrometry through automation and standardization, Baoshipu enables hospitals to implement precise diagnostic workflows with higher efficiency. The company is headquartered in Shanghai and is supported by leading venture capital investors in the healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baoship Biotechnology.